AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) - AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter.